Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:04 PM
Ignite Modification Date:
2025-12-24 @ 4:04 PM
NCT ID:
NCT06057766
Eligibility Criteria:
Inclusion Criteria:
* Resectable (I-IIIA) NSCLC patients who had lung resection surgery, one to twelve months before inclusion, with or without (neo-)adjuvant chemotherapy/radiotherapy/immunotherapy.
* If patients received adjuvant chemotherapy/radiotherapy, the inclusion window is one months to twelve months after the end of adjuvant chemotherapy/radiotherapy.
* If patients receive adjuvant immunotherapy after the end of adjuvant chemotherapy, patients can be included during the immunotherapy.
* Adults (18+ year)
* Patients who do not systematically perform structured exercise or are planned to do so.
* Ability to give informed consent
Exclusion Criteria:
* Patients having progressive or recurrent lung cancer
* Patients who had other malignancies in the last 2 years
* Psychiatric disorders that preclude them from participation in a physical activity intervention and/or performing the test battery
* Unable to learn to work with a new electronic device (e.g. smartphone)
* Not understanding and speaking Dutch
* Patients with comorbidities or other treatments that preclude them from participation in a physical activity intervention and/or performing the test battery
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06057766
Study Brief:
Protocol Section:
NCT06057766